Carboplatin in EARLY Triple Negative Breast Cancer Trial (PEARLY Trial)
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: taxane plus carboplatin|DRUG: Taxane
Sponsor: Yonsei University